Dergiler / GORM:Gynecology Obstetrics & Reproductive Medicine / 2022 / Cilt: 28 - Sayı: 1

Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and OverIntracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and Over

Sayfa
38–43
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In patients between the ages of 40-43, the live birth rate is acceptable but starting an in vitro fertilization cycle beyond 43 years of age does not seem to be reasonable.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: The main detrimental factor in female fertility is maternal age.
📊
Temel Bulgular & Veri:Clinical pregnancy and live birth rates decline gradually with age and this decline is dramatical over 40 years.
💡
Sonuç & Katkı:In patients between the ages of 40-43, the live birth rate is acceptable but starting an in vitro fertilization cycle beyond 43 years of age does not seem to be reasonable.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE: The main detrimental factor in female fertility is maternal age. Clinical pregnancy and live birth rates decline gradually with age and this decline is dramatical over 40 years. In this study, we examined the in vitro fertilization/intracytoplasmic sperm injection cycle outcomes of women aged 40 years and over. STUDY DESIGN: This retrospective cohort study included 336 fresh in vitro fertilization/ICSI cycles of women aged ≥40 years. Six groups, stratified by one-year intervals were composed according to age: 40 years; 41 years; 42 years; 43 years; 44 years, and ≥45 years. The primary outcomes were the clinical pregnancy and live birth rates. RESULTS: The clinical pregnancy rate was 18.6% in 40 years old women and it decreased to 4% in women aged ≥45 years. The live birth rates in women aged 40 and 41 years (10% and 6.1% respectively) were higher than the live birth rates in women aged 42 and 43 years (4.3% and 3.8% respectively). There was no live birth in women aged 44 and over. The miscarriage rate was 46.2% at age 40 and it increased to 100% at age 44 and over. CONCLUSION: The clinical pregnancy and the live birth rates decreased significantly with every single year after 40 years of age. In patients between the ages of 40-43, the live birth rate is acceptable but starting an in vitro fertilization cycle beyond 43 years of age does not seem to be reasonable.

🔖

Bu Makaleye Atıf Yap

USTUN, Y., BASER, E., DILBAZ, B., OZELCI, R., ALDEMIR, O., DILBAZ, S. (2022). Intracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and OverIntracytoplasmic Sperm Injection Cycle Outcomes in Women Aged 40 Years and Over. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 28 - Sayı: 1, 38–43. https://ajindex.com/articles/525801

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30(5):465-93. Doi: 10.1210/er.2009-0006
  2. Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence. Front Endocrinol (Lausanne). 2018;9:327. Doi: 10.3389/fendo. 2018.00327
  3. Speroff L, Fritz M. Female infertility in: Clinical Gynecologic Endocrinology and Infertility. 9th Eds. USA: Lippincott Williams & Wilkins; 2020
  4. Pinheiro RL, Areia AL, Mota Pinto A, Donato H. Advanced maternal age: adverse outcomes of pregnancy, a meta-analysis. Acta Med Port. 2019;32(3):219-26. Doi: 10.20344/amp.11057
  5. Tan TY, Lau SK, Loh SF, Tan HH. Female ageing and reproductive outcome in assisted reproduction cycles. Singapore Med J. 2014;55(6):305-9. Doi: 10.11622/ smedj.2014081
  6. Kim HO, Sung N, Song IO. Predictors of live birth and pregnancy success after in vitro fertilization in infertile women aged 40 and over. Clin Exp Reprod Med. 2017;44(2):111-7. Doi: 10.5653/cerm.2017.44.2.111
  7. Serour G, Mansour R, Serour A, Aboulghar M, Amin Y, Kamal O, et al. Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above. Fertil Steril. 2010;94(5):1707-12. Doi: 10.1016/j.fertnstert.2009.09.044
  8. Calhaz-Jorge C, De Geyter CH, Kupka MS, Wyns C, Mocanu E, Motrenko T, et al. Survey on ART and IUI: legislation, regulation, funding and registries in European countries: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod Open. 2020; 2020(1): hoz044. Doi: 10.1093/hropen/hoz044
  9. Baczkowski T, Kurzawa R, Glabowski W. Methods of embryo scoring in in vitro fertilization. Reprod Biol. 2004;4(1):5-22. PMID: 15094792
  10. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73(6):1155-8. Doi: 10.1016/ s0015-0282(00)00518-5
  11. Sbracia M, Farina A, Poverini R, Morgia F, Schimberni M, Aragona C. Short versus long gonadotropin-releasing hormone analogue suppression protocols for superovulation in patients > or = 40 years old undergoing intracytoplasmic sperm injection. Fertil Steril. 2005;84(3):644-8. Doi: 10.1016/j.fertnstert.2005.02.046
  12. Sbracia M, Colabianchi J, Giallonardo A, Giannini P, Piscitelli C, Morgia F